METTL1-driven epitranscriptomic enhancement of TXNDC12 boosts c-Myc stability through USP5 in HNSCC.

Exp Mol Med · 2025 · PMC12411639 · PMID 40750708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a similar trend was observed in advanced-stage patients (TNM stage III–IV), the difference did not reach statistical significance (Supplementary Fig. 3b ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.